Literature DB >> 24426512

Giant fibroadenoma masquerading as cystosarcoma phylloides in an elderly lady-a case report and review of literature.

Preethi Shivanna Puttasubbappa1, P Pallavi2, Ravi M Jeevan1, Sanket B Shah1.   

Abstract

Giant Fibroadenoma is commonly seen in young women. Here, we are reporting the case of an elderly lady who was diagnosed with Cystosarcoma Phylloides clinically and by FNAC. Simple mastectomy was performed and histopathology revealed a Giant Fibroadenoma. This report focuses on the rarity of the age of presentation, confusing clinical features, role of FNAC and histopathology, the need to differentiate them and the modalities of treatment.

Entities:  

Keywords:  Cystosarcoma phylloides; Giant fibroadenoma

Year:  2011        PMID: 24426512      PMCID: PMC3693375          DOI: 10.1007/s12262-011-0335-1

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  5 in total

1.  Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.

Authors:  S Veneti; S Manek
Journal:  Cytopathology       Date:  2001-10       Impact factor: 2.073

2.  Surgical management of phyllodes tumors.

Authors:  A A Mangi; B L Smith; M A Gadd; K K Tanabe; M J Ott; W W Souba
Journal:  Arch Surg       Date:  1999-05

3.  The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.

Authors:  M Reinfuss; J Mituś; K Duda; A Stelmach; J Ryś; K Smolak
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

4.  Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.

Authors:  Naruto Taira; Daisuke Takabatake; Kenjiro Aogi; Shozo Ohsumi; Shigemitsu Takashima; Rieko Nishimura; Norihiro Teramoto
Journal:  Jpn J Clin Oncol       Date:  2007-10-11       Impact factor: 3.019

5.  Differentiation of phyllodes tumors versus fibroadenomas.

Authors:  Erkan Yilmaz; S Sal; B Lebe
Journal:  Acta Radiol       Date:  2002-01       Impact factor: 1.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.